Neuigkeiten | Smiths Medical

Product Announcements and Company News

Informieren Sie sich über Neuigkeiten, Produktankündigungen und Werbeaktionen von Smiths Medical.

Weitere Informationen erhalten Sie von unserem Pressekontakt.
  1. Sicherheitsprodukte für scharfe/spitze Instrumente
    Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe with Skewed Graduation Markings
    Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels.
  2. Beatmungsgeräte
    Introducing the Portex® Acapella® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

    Smiths Medical announces the launch of the acapella® choice blue vibratory PEP therapy system. Acapella® is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

  3. Infusionsprodukte
    Smiths Medical partners with Parkview Health to enhance patient and clinician safety
    Parkview Health’s integration of the Smiths Medical PharmGuard® Infusion Management System enables smart pump programming and auto documentation to improve safety.
  4. Infusionsprodukte
    ECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion System
    The report highlights ECRI’s evaluation ratings, test results, and purchasing recommendations for the CADD®-Solis pump.
  5. Produkte für das Schmerzmanagement
    Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio
    Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.
  6. Infusionsprodukte
    CADD®-Solis Wireless Communication - Cybersecurity Bulletin

    Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-011 (the “Advisory”).

  7. Infusionsprodukte
    Das Smiths Medical Schmerz-Management System mit drahtloser Kommunikation
    Smiths Medical, ein führendes, globales MedTech Unternehmen, hat eine neue Version der CADD®-Solis Pumpe, die CADD Solis V4.2 herausgebracht und damit weltweit eine Grundlage für die drahtlose Kommunikation in der Infusionstherapie geschaffen.
  8. Infusionsprodukte
    Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion Pumps
    Due to a software error, if a bolus or loading dose is interrupted and a specific sequence of events occurs, over- or under-delivery of a bolus or loading dose may occur.
  9. Sicherheitsprodukte für scharfe/spitze Instrumente
    Smiths Medical partners with U.S. government on COVID-19 vaccine efforts
    The partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.
  10. Infusionsprodukte
    Smiths Medical Cybersecurity Bulletin

    Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01

  11. Infusionsprodukte
    No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities

    The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.

  12. Infusionsprodukte
    Smith Medical announces first hospital to implement smart pump programming with the Medfusion® 4000 wireless syringe pump and PharmGuard® infusion management system

    Smart pump programming will allow the Medfusion® 4000 pumps to be programmed based on the clinician order, minimizing programming errors.